These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis. Zhu X; Liu F; Liu Y; Liu H; Xu X; Peng Y; Sun L; Yuan S Clin Lab; 2011; 57(11-12):947-52. PubMed ID: 22239026 [TBL] [Abstract][Full Text] [Related]
23. Morphological and clinical features of renal amyloidosis. Watanabe T; Saniter T Virchows Arch A Pathol Anat Histol; 1975; 366(2):125-35. PubMed ID: 805487 [TBL] [Abstract][Full Text] [Related]
24. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy. Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779 [TBL] [Abstract][Full Text] [Related]
25. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis. Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929 [TBL] [Abstract][Full Text] [Related]
26. Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis. Kuroda T; Tanabe N; Kobayashi D; Wada Y; Murakami S; Nakano M; Narita I BMC Nephrol; 2012 Sep; 13():118. PubMed ID: 23006903 [TBL] [Abstract][Full Text] [Related]
27. Renal amyloidosis: immunofluorescence and electron microscopy studies. Müftüoğlu AU; Erbengi T; Harmanci M; Karayel T; Gürsoy E; Tahsinoğlu M Isr J Med Sci; 1977 Nov; 13(11):1102-8. PubMed ID: 591304 [TBL] [Abstract][Full Text] [Related]
28. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293 [TBL] [Abstract][Full Text] [Related]
29. Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities. Mancilla E; Avila-Casado C; Uribe-Uribe N; Morales-Buenrostro LE; Rodríguez F; Vilatoba M; Gabilondo B; Aburto S; Rodríguez RM; Magaña S; Magaña F; Alberú J Transplantation; 2008 Dec; 86(12):1684-8. PubMed ID: 19104405 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for renal amyloidosis: a clinicopathological study using cluster analysis. Sasatomi Y; Sato H; Chiba Y; Abe Y; Takeda S; Ogahara S; Murata T; Kaneoka H; Takebayashi S; Iwasaki H; Saito T Intern Med; 2007; 46(5):213-9. PubMed ID: 17329915 [TBL] [Abstract][Full Text] [Related]
32. Coincidental amyloid nephropathy and IgA glomerulonephritis in a patient with ankylosing spondylitis. Gratacós J; Collado A; Sanmartí R; Poch E; Torras A; Muñoz-Gomez J J Rheumatol; 1993 Sep; 20(9):1613-5. PubMed ID: 8164228 [TBL] [Abstract][Full Text] [Related]
33. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis. Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962 [TBL] [Abstract][Full Text] [Related]
34. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis. Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512 [TBL] [Abstract][Full Text] [Related]
35. Functional outcomes following percutaneous surgery in the solitary kidney. Canes D; Hegarty NJ; Kamoi K; Haber GP; Berger A; Aron M; Desai MM J Urol; 2009 Jan; 181(1):154-60. PubMed ID: 19013616 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis. Danilewicz M; Wagrowska-Danilewicz M Pol J Pathol; 2006; 57(4):193-8. PubMed ID: 17285762 [TBL] [Abstract][Full Text] [Related]
38. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy. Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473 [TBL] [Abstract][Full Text] [Related]
39. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068 [TBL] [Abstract][Full Text] [Related]
40. Immunofluorescence study of childhood renal amyloidosis. Tinaztepe K; Güçer KS Turk J Pediatr; 1992; 34(1):5-14. PubMed ID: 1509531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]